Predictive serum metabolic markers in GDM patients: A targeted metabolomics study combined with machine learning of sex steroid hormones

doi: 10.1016/j.jpha.2025.101530

• Yi Xu^a,b,c , 
• Zhulin Gu^a , 
• Li Wang^a , 
• Xinghan Liu^c , 
• Hao Wu^a , 
• Zhenzhou Jiang^d , 
• Jinfang Song^e , 
• Changjiang Ying^f , 
• Tan Li^g , 
• Tao Wang^{a,h ,  ,}  , 
• Na Xie^{a,g ,  ,}  , 
• Xiaoxing Yin^{a ,  ,}  , 
• Tingting Yang^{a ,  ,} 

• a. Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, Xuzhou, Jiangsu, 221004, China;

• b. Phase I Clinical Trial Center, Affiliated Lianyungang Hospital of Xuzhou Medical University, Lianyungang, Jiangsu, 222000, China;

• c. Kangda college of Nanjing Medicine University, Lianyungang, Jiangsu, 222000, China;

• d. New Drug Screening Center, Jiangsu Center for Pharmacodynamics Research and Evaluation, China Pharmaceutical University, Nanjing, 210009, China;

• e. Department of Pharmacy, Affiliated Hospital of Jiangnan University, Wuxi, Jiangsu, 214000, China;

• f. Department of Endocrinology, Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, 221006, China;

• g. Department of Obstetrics and Gynecology, The affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, 221006, China;

• h. Department of Pharmacy, Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, 221006, China